May 22, 2001
And Reproductive Partners Combine To Deliver
Advanced Care In Reproductive Technology
UCSD School of Medicine reproductive endocrinologists and physicians of Reproductive Partners Medical Group in La Jolla have joined to form Reproductive Partners-UCSD Regional Fertility Center. RP-UCSD Regional Fertility Center brings together a highly successful assisted reproductive technology (ART) program with an academic center known for its clinical and research expertise in the field of human reproduction.
Seth Katz, M.D., UCSD School of Medicine reproductive endocrinologist, has been working with Gabriel Garzo, M.D., and David Meldrum, M.D., of RPMG’s La Jolla office since March of 2000. Because the arrangement has proven to be extremely beneficial to both programs, it was recently agreed to formally acknowledge the partnership by virtue of a name change.
“We envision that working together this collaboration will greatly enhance the treatment options for our patients and stimulate innovative future reproductive therapies, which will increase the number of safe and successful pregnancy outcomes,” said Dr. Garzo, Medical Director of RP-UCSD Regional Fertility Center.
“This is a wonderful opportunity to align the outstanding success of a superb ART program with the scientific excellence of a nationally recognized research program in the field of reproduction,” said R. Jeffrey Chang, M.D., Director of Reproductive Endocrinology and Infertility at UCSD, who will be a medical administrator with RP-UCSD Regional Fertility Center.
RPMG,Inc is a well-established and internationally renowned fertility center with five offices throughout the Southern California region. In San Diego, the current pregnancy success rates of RPMG are well above the recently calculated national average as compiled by the Centers for Disease Control in Atlanta. For instance, in 1998, the year for which the latest published result are available, RPMG reported a live birth rate per cycle of 36 percent in women up to 40 years compared to the national average of 27 percent. In 1999, the live birth rate increased to 39.4 percent.
UCSD’s division of reproductive endocrinology has received international acclaim for its state-of-the-art patient care and cutting edge research. It is a designated Center for Reproductive Research by the National Institutes of Child Health and Human Development and is in its 23rd year of continuous funding by this federal agency.
Operating out of the Scripps/XiMed building in La Jolla, Drs. Garzo, Meldrum and Katz will provide comprehensive care to patients seeking assisted reproductive treatments.
The partnership will serve to reinforce both the clinical and scientific aspects of reproduction, Dr. Chang said. It is expected that research efforts of the division will provide for new discoveries, which may eventually facilitate and further improve clinical reproductive outcomes. Additionally, insight into reproductive problems in clinical practice will spawn new research ideas. The ultimate goal is to provide the most suitable options and care for individuals suffering from infertility.
Patients of RP-UCSD Regional Fertility Center will benefit from a comprehensive approach to care, from the initial evaluation and first line management of newly discovered fertility cases to complex situations, which may require advanced reproductive services such as in vitro fertilization and embryo transfer.
# # #
Media Contact: Kate Deely Smith
Return to UCSD Health Sciences Communications HealthBeat http://health.ucsd.edu/news/